Evidence map›Paper›PMID 38869772›Full record

ArticleTranslational stroke research2025

Loss of Epitranscriptomic Modification N

Anil K Chokkalla, Vijay Arruri, Suresh L Mehta, Raghu Vemuganti

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational stroke research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anil K Chokkalla *Department of Neurological Surgery, University of Wisconsin, Madison, WI, 53792, USA.
Vijay Arruri *Department of Neurological Surgery, University of Wisconsin, Madison, WI, 53792, USA.
Suresh L MehtaDepartment of Neurological Surgery, University of Wisconsin, Madison, WI, 53792, USA.
Raghu VemugantiDepartment of Neurological Surgery, University of Wisconsin, Madison, WI, 53792, USA. vemuganti@neurosurgery.wisc.edu.

Funding

DNA hydroxymethylation and post stroke brain damageR01NS109459 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI VEMUGANTI, RAGHU · 2018 to 2022
$2.1M
Therapeutic Targeting of an lncRNA in Experimental Stroke Using STAIR CriteriaR01NS099531 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI VEMUGANTI, RAGHU · 2017 to 2021
$2.0M
Targeting alpha-synuclein after cerebral ischemia as a function of sex and ageR01NS101960 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI VEMUGANTI, RAGHU · 2017 to 2021
$1.6M
Epitranscriptomic regulation by m6A RNA methylation after strokeR01NS130763 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI VEMUGANTI, RAGHU · 2023 to 2023
$618k
American Heart Association 20PRE3512023, 24POST1198978BLRD VA I01 BX004344BLRD VA I01 BX005127BLRD VA IK6 BX005690NIH HHS RO1 NS109459, RO1 NS099531 and RO1 NS101960NINDS NIH HHS R01 NS099531NINDS NIH HHS R01 NS101960NINDS NIH HHS R01 NS109459NINDS NIH HHS R01 NS130763U.S. Department of Veterans Affairs I01 BX005127, I01 BX004344
6 · The paper itself

Abstract

N

Indexed as

AdenosineBrain IschemiaEpigenesis, GeneticRNA-Binding ProteinsSex CharacteristicsAnimalsFemaleInfarction, Middle Cerebral ArteryMaleMiceMice, Inbred C57BLMice, KnockoutAdenosineN-methyladenosineRNA-Binding ProteinsYthdf1 protein, mouseEpitranscriptomem6A readerSexual dimorphismStrokeYTHDF1

Identifiers

PMID38869772
PMCPMC12066170

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.